-

JRCT ID: jRCT2080222202

Registered date:27/08/2013

Basic Information

• Recruitment status: completed
• Date of first enrollment: 26/04/2013
• Target sample size: 84
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

investigational material(s)
Generic name etc :
INN of investigational material : Pembrolizumab
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Cisplatin,Pemetrexed
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Carboplatin,Pemetrexed
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Carboplatin,Pemetrexed
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Carboplatin
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Ipilimumab
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Cisplatin,Etoposide
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Carboplatin,Etoposide
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :
Generic name etc :
INN of investigational material : Pembrolizumab,Carboplatin,Etoposide,Pegfilgrastim
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material :

control material(s)
Generic name etc :
INN of investigational material : -
Therapeutic category code :
Dosage and Administration for Investigational material :

Outcome(s)

• Primary Outcome: safety

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Related Information

• Primary Sponsor: -
• Secondary Sponsor: -
• Secondary ID(s): NCT01840579,JapicCTI-132249